Researchers sought to pinpoint the molecular drivers of idiopathic membranous nephropathy pathogenesis, evaluate their expression profiles alongside clinical parameters, and examine their functional contributions to cellular damage within renal podocytes.
To uncover primary candidate genes involved in the disorder, investigators analyzed two distinct Gene Expression Omnibus datasets using the LIMMA package in R. The bioinformatic workflow examined GSE73953, a blood-derived expression dataset, alongside GSE216841, an expression dataset derived from glomerular tissue, to detect differentially expressed genes across separate biological compartments.
The computational analysis identified 1,138 differentially expressed genes in the blood-derived GSE73953 dataset and 1,291 differentially expressed genes in the glomerular-derived GSE216841 dataset. Comparing the two datasets revealed 57 overlapping differentially expressed genes that were shared across both the circulating blood and glomerular tissues.
The researchers subsequently subjected the individual differentially expressed genes and the 57 overlapping candidate genes to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. To further isolate clinically relevant candidates, the overlapping genes were evaluated against key clinical indicators using the Nephroseq database, allowing the team to narrow the broader gene list down to five prioritized candidates: VSIG4, TNFRSF12A, B3GNT7, RAB27A, and ALPK1.
For clinical confirmation, the investigators examined gene expression in peripheral blood mononuclear cells collected from human subjects using quantitative real-time PCR. This validation demonstrated that VSIG4 levels were significantly elevated in peripheral blood mononuclear cells from patients with idiopathic membranous nephropathy compared with both healthy controls and patients diagnosed with IgA nephropathy, with statistical significance recorded at P < 0.05.
Statistical evaluations showed that elevated VSIG4 expression was correlated with clinical indicators and disease severity in patients with idiopathic membranous nephropathy. To assess its potential diagnostic utility, the researchers performed receiver operating characteristic curve analyses, evaluating the performance of the biomarker in distinguishing clinical disease states.
To investigate the functional role of the key gene in cellular pathology, the research team established an in vitro model of podocyte injury induced by the complement membrane attack complex C5b-9. Through cellular transfection and western blot analyses, the team preliminarily demonstrated that silencing VSIG4 expression helped alleviate complement-mediated podocyte injury.
These experimental and bioinformatic findings establish an initial framework for future mechanistic evaluations and targeted therapeutic interventions for idiopathic membranous nephropathy.
Subject of Research: Role of VSIG4 expression in idiopathic membranous nephropathy and podocyte injury
Article Title: Integrated transcriptomic analysis with experimental validation reveals the potential pathogenic role of VSIG4 in idiopathic membranous nephropathy
Article References: Bai, Y., Hu, M., Zhang, J., Deng, Y., & Zhou, L. (2026). Integrated transcriptomic analysis with experimental validation reveals the potential pathogenic role of VSIG4 in idiopathic membranous nephropathy. European Journal of Medical Research. https://doi.org/10.1186/s40001-026-05468-5
Image Credits: AI Generated
DOI: 10.1186/s40001-026-05468-5
Keywords: idiopathic membranous nephropathy, VSIG4, podocytes, podocyte injury, transcriptomic analysis, differentially expressed genes, GSE73953, GSE216841, Gene Expression Omnibus, Nephroseq, peripheral blood mononuclear cells, qRT-PCR, complement C5b-9, western blotting, receiver operating characteristic, TNFRSF12A, B3GNT7, RAB27A, ALPK1
News Source: Juliet Wilcox. (November 13, 2026). Study Links Elevated VSIG4 Expression to Podocyte Injury in Membranous Nephropathy. Scienmag.



